Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.4800
+0.0300 (6.67%)
Aug 3, 2026, 2:14 PM EDT - Market open
Traws Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.13 | 3.82 | 21.34 | 20.82 | 38.76 | 0.06 |
Cash & Short-Term Investments | 3.13 | 3.82 | 21.34 | 20.82 | 38.76 | 0.06 |
Cash Growth | -80.34% | -82.10% | 2.48% | -46.28% | 70277.70% | -99.71% |
Other Receivables | 1.69 | 3.79 | 1.77 | 0.02 | 0.03 | 0 |
Total Trade Receivables | 1.69 | 3.79 | 1.77 | 0.02 | 0.03 | 0 |
Other Current Assets | 0.85 | 0.37 | 1.85 | 1.82 | 0.56 | 0 |
Total Current Assets | 5.67 | 7.98 | 24.95 | 22.66 | 39.35 | 0.06 |
Net Property, Plant & Equipment | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0 |
Other Intangible Assets | 2.48 | 2.53 | - | - | - | - |
Other Long-Term Assets | 0 | 0.1 | 0 | 0 | 0 | 0 |
Total Assets | 8.16 | 10.62 | 24.96 | 22.68 | 39.37 | 0.06 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 7.67 | 5.65 | 8.19 | 5.62 | 3.86 | 0 |
Accrued Expenses | 5.54 | 5.49 | 3.12 | 3.38 | 3.96 | 0 |
Unearned Revenue | - | - | 0.23 | 0.23 | 0.23 | 0 |
Total Current Liabilities | 13.21 | 11.15 | 11.53 | 9.22 | 8.05 | 0.01 |
Other Long-Term Liabilities | 0.26 | 0.1 | 45.06 | 2.79 | 3.02 | 0 |
Total Long-Term Liabilities | 0.26 | 0.1 | 45.06 | 2.79 | 3.02 | 0 |
Total Liabilities | 13.47 | 11.25 | 56.59 | 12.01 | 11.06 | 0.01 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.1 | 0.09 | 0.04 | 0.01 | 0.21 | 0 |
Additional Paid-in Capital | 641.68 | 639.26 | 617.53 | 493.32 | 491.82 | 0.49 |
Accumulated Other Comprehensive Income | -0 | 0.01 | -0.04 | -0.02 | -0.03 | -0 |
Retained Earnings | -647.09 | -639.98 | -649.15 | -482.63 | -463.68 | -0.44 |
Shareholders' Equity | -5.31 | -0.63 | -31.63 | 10.67 | 28.31 | 0.05 |
Total Liabilities & Equity | 8.16 | 10.62 | 24.96 | 22.68 | 39.37 | 0.06 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 3.13 | 3.82 | 21.34 | 20.82 | 38.76 | 0.06 |
Net Cash Growth | -80.34% | -82.10% | 2.48% | -46.28% | 70277.70% | -99.71% |
Net Cash Per Share | 0.36 | 0.46 | 13.74 | 24.80 | 1.85 | 0.00 |
Book Value | -5.31 | -0.63 | -31.63 | 10.67 | 28.31 | 0.05 |
Book Value Per Share | -0.61 | -0.08 | -20.37 | 12.71 | 1.35 | 0.00 |
Tangible Book Value | -7.8 | -3.16 | -31.63 | 10.67 | 28.31 | 0.05 |
Tangible Book Value Per Share | -0.90 | -0.38 | -20.37 | 12.71 | 1.35 | 0.00 |